Lebrikizumab (RO5490255)

Lebrikizumab · Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lebrikizumab (RO5490255), covering 2017-05-22 to 2017-05-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Lebrikizumab (RO5490255) in Participants With Severe Oral Corticosteroids (OCS) Dependent Asthma [Phase 2]

See pricing